144 related articles for article (PubMed ID: 11580302)
1. Immunological approaches to the treatment of spinal cord injury.
Schwartz M
BioDrugs; 2001; 15(9):585-93. PubMed ID: 11580302
[TBL] [Abstract][Full Text] [Related]
2. Innate and adaptive immune responses can be beneficial for CNS repair.
Schwartz M; Moalem G; Leibowitz-Amit R; Cohen IR
Trends Neurosci; 1999 Jul; 22(7):295-9. PubMed ID: 10370250
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and pathways of inflammatory responses in CNS trauma: spinal cord injury.
Anderson AJ
J Spinal Cord Med; 2002; 25(2):70-9; discussion 80. PubMed ID: 12137220
[TBL] [Abstract][Full Text] [Related]
4. T cell-based therapeutic vaccination for spinal cord injury.
Schwartz M; Hauben E
Prog Brain Res; 2002; 137():401-6. PubMed ID: 12440382
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury.
Hauben E; Nevo U; Yoles E; Moalem G; Agranov E; Mor F; Akselrod S; Neeman M; Cohen IR; Schwartz M
Lancet; 2000 Jan; 355(9200):286-7. PubMed ID: 10675079
[TBL] [Abstract][Full Text] [Related]
6. New hope for spinal-cord repair from immune activation.
Gurwitz D
Mol Med Today; 2000 Nov; 6(11):415. PubMed ID: 11074363
[No Abstract] [Full Text] [Related]
7. Immune-based therapy for spinal cord repair: autologous macrophages and beyond.
Schwartz M; Yoles E
J Neurotrauma; 2006; 23(3-4):360-70. PubMed ID: 16629622
[TBL] [Abstract][Full Text] [Related]
8. Effects of autoimmunity on recovery of function in adult rats following spinal cord injury.
Lü HZ; Xu L; Zou J; Wang YX; Ma ZW; Xu XM; Lu PH
Brain Behav Immun; 2008 Nov; 22(8):1217-30. PubMed ID: 18625299
[TBL] [Abstract][Full Text] [Related]
9. Spinal cord injury impacts B cell production, homeostasis, and activation.
Oropallo MA; Goenka R; Cancro MP
Semin Immunol; 2014 Oct; 26(5):421-7. PubMed ID: 25443579
[TBL] [Abstract][Full Text] [Related]
10. Immunobiology of spinal cord injuries and potential therapeutic approaches.
Ahmed A; Patil AA; Agrawal DK
Mol Cell Biochem; 2018 Apr; 441(1-2):181-189. PubMed ID: 28884424
[TBL] [Abstract][Full Text] [Related]
11. Helping The Body To Cure Itself: Immune Modulation By Therapeutic Vaccination For Spinal Cord Injury.
Schwartz M
J Spinal Cord Med; 2003 Jan; 26(sup1):S6-S10. PubMed ID: 27700258
[TBL] [Abstract][Full Text] [Related]
12. Influence of the intensity, level and phase of spinal cord injury on the proliferation of T cells and T-cell-dependent antibody reactions in rats.
Ibarra A; Jiménez A; Cortes C; Correa D
Spinal Cord; 2007 May; 45(5):380-6. PubMed ID: 16955070
[TBL] [Abstract][Full Text] [Related]
13. Potential immunotherapies for traumatic brain and spinal cord injury.
Putatunda R; Bethea JR; Hu WH
Chin J Traumatol; 2018 Jun; 21(3):125-136. PubMed ID: 29759918
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune involvement in CNS trauma is beneficial if well controlled.
Schwartz M
Prog Brain Res; 2000; 128():259-63. PubMed ID: 11105685
[No Abstract] [Full Text] [Related]
15. Beneficial immune activity after CNS injury: prospects for vaccination.
Schwartz M; Moalem G
J Neuroimmunol; 2001 Feb; 113(2):185-92. PubMed ID: 11164901
[TBL] [Abstract][Full Text] [Related]
16. Improved regeneration after spinal cord injury in mice lacking functional T- and B-lymphocytes.
Wu B; Matic D; Djogo N; Szpotowicz E; Schachner M; Jakovcevski I
Exp Neurol; 2012 Oct; 237(2):274-85. PubMed ID: 22868200
[TBL] [Abstract][Full Text] [Related]
17. Beneficial autoimmune T cells and posttraumatic neuroprotection.
Schwartz M
Ann N Y Acad Sci; 2000; 917():341-7. PubMed ID: 11268361
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.
Kipnis J; Mizrahi T; Hauben E; Shaked I; Shevach E; Schwartz M
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15620-5. PubMed ID: 12429857
[TBL] [Abstract][Full Text] [Related]
19. The immunological response to spinal cord injury: helpful or harmful?
Laliberte AM; Fehlings MG
Exp Neurol; 2013 Sep; 247():282-5. PubMed ID: 23333564
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens.
Hauben E; Ibarra A; Mizrahi T; Barouch R; Agranov E; Schwartz M
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15173-8. PubMed ID: 11752461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
